| P/E (FY) | — | Sales (TTM) | £14.21B |
| Earnings (TTM) | £3.18B | ROE | 44.06% |
| Net Margin | 22.40% | ROIC | 24.48% |
| Debt / Equity | 1.09 | TD / EBITDA | 1.70 |
| EPS Growth 3Y | 12.89% | Sales Growth 3Y | −0.58% |
Reckitt Benckiser Group manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. Its brands include Dettol, Durex, over-the-counter products such as Gaviscon, Mucinex, and Nurofen, personal care lines Clearasil and Veet, vitamins and supplements, stain removal under Vanish, disinfectants under Finish, Harpic, and Lysol, and infant nutrition under Enfamil and Nutramigen.
| Market Cap | — | Trading Days | 4133 |
| 52W High | 6514.00 |
| 52W Low | 3664.00 |
| % Off High | −24.01% |
| YTD | −17.53% | 1Y | −11.98% |
| 3Y | −16.04% | 5Y | −20.48% |
| 10Y | −33.60% | Since incept. (ann.) | 2.53% |
| Ann. Volatility (1Y) | 20.80% | Ann. Volatility (3Y) | 24.48% |
| Sharpe (1Y) | −0.52 | Sharpe (3Y) | −0.13 |
| Max Drawdown (1Y) | −31.77% | Max Drawdown (3Y) | −31.77% |
| Beta (3Y, vs SPY) | 0.11 |
No same-industry peers in the universe for RKT.L.
